Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)
Constance Thibault, Aude Fléchon, Laurence Albigès, Charlotte Joly, Philippe Barthélémy, Marine Gross-Goupil, Christine Chevreau, Elodie Coquan, Frédéric Rolland, Brigitte Laguerre, Gwénaëlle Gravis, Nicolas Pécuchet, Réza-Thierry Elaidi, Marc‐Olivier Timsit, Meryem Brihoum, Édouard Auclin, Aurélien de Reyniès, Yves Allory, Stéphane Oudard
Topics & Concepts
GemcitabineBevacizumabMedicineOncologyChemotherapyInternal medicineMedullary cavityCabozantinibRenal cell carcinomaRenal cell carcinoma treatmentPancreatic and Hepatic Oncology ResearchBladder and Urothelial Cancer Treatments